Actively Recruiting
Endovascular Recanalization for Symptomatic Chronic Intradural Occlusions
Led by Insel Gruppe AG, University Hospital Bern · Updated on 2025-07-18
80
Participants Needed
2
Research Sites
32 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Background: Chronic intracranial large vessel occlusion (LVO), resulting from progressive atherosclerosis or thrombosis, contributes significantly to ischemic strokes, 8-10% in North America and up to 50% in the Chinese population. This condition leads to cerebral hypoperfusion, brain ischemia, and potentially cognitive impairment. While extra-to-intracranial bypass surgery has shown limited benefit, recent advances in endovascular treatment (EVT) for acute ischemic stroke show promise. Preliminary reports suggest EVT may be feasible for chronic intracranial artery occlusions. Still, outcomes vary and perioperative risks remain high, particularly for intradural occlusions, which are technically more challenging and less studied. Objectives: This study aims to evaluate the feasibility, safety, and clinical outcomes of EVT for symptomatic chronic intradural large vessel occlusions. Primary endpoints include technical success, complication rates, and functional outcomes, as measured by the modified Rankin Scale (mRS) at 3 months and the last follow-up. Safety endpoints include mortality, ischemic stroke, and periprocedural complications. Design: A multicenter, retrospective and prospective observational study involving 10-20 experienced centers worldwide. Data from approximately 40-80 patients treated between January 2020 and December 2024 will be collected by local neuroradiologists, neurologists, or neurosurgeons. Clinical data (demographics, comorbidities, symptoms, outcomes), imaging data (pre-, post-, and follow-up), procedural details, and medication regimens will be collected. Inclusion criteria target adult patients with symptomatic chronic intradural occlusions of key intracranial arteries (ICA, MCA, VA, BA). Symptomatic occlusion is defined by neurological deficits or imaging evidence of ischemia. The data analysis will be performed by the local team at the Inselspital, Bern, Switzerland. Aim: To descriptively analyze patient characteristics, treatment approaches, complications, and hemodynamic changes post-EVT to inform future therapeutic strategies for this challenging condition.
CONDITIONS
Official Title
Endovascular Recanalization for Symptomatic Chronic Intradural Occlusions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who underwent endovascular recanalization for chronic intradural large vessel occlusions between January 1, 2020, and December 31, 2024
- Occlusions located in the internal carotid artery (ICA), middle cerebral artery (MCA), vertebral artery (VA), or basilar artery (BA)
You will not qualify if you...
- Patients who have given documented written or verbal refusal to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Alfried Krupp Krankenhaus
Essen, Germany, 45131
Actively Recruiting
2
Inselspital Bern, University Hospital Bern
Bern, Switzerland, 3010
Actively Recruiting
Research Team
P
Petra Cimflova, MD, PhD
CONTACT
J
Jan Gralla, Prof. Dr. med.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here